We recently compiled a list of the 10 Worst Performing Healthcare Stocks in 2024. In this article, we are going to take a ...

Bearish flow noted in Biogen (BIIB) with 1,136 puts trading, or 1.1x expected. Most active are Apr-25 160 puts and 11/29 weekly 162.5 calls, ...

The Dow Jones Industrial Average is falling Tuesday morning with shares of Amgen and Boeing facing the biggest drops for the index.

Roche has struck a $1.5 billion deal to buy Poseida Therapeutics. The takeover will establish off-the-shelf cell therapies, ...

Cambridge, Massachusetts-based Biogen Inc. ( BIIB) discovers, develops, manufactures, and delivers therapies for treating ...

Biogen (NASDAQ:BIIB – Free Report) had its price objective decreased by Mizuho from $251.00 to $207.00 in a research note published on Thursday,Benzinga reports. Mizuho currently has an outperform ...

The volume of shares traded was 1.70 million exceeding the average volume of 1.31 million. In recent trading, Biogen Inc (BIIB) stock price has shown some volatility, fluctuating -1.31% over the last ...

Compared to the Medical - Products industry's P/E of 26.3X, shares of GE HealthCare Technologies are trading at a forward P/E of 19.1X. GEHC also has a PEG Ratio of 2.9, a Price/Cash Flow ratio of ...

The volume of shares traded was 1.62 million exceeding the average volume of 1.27 million. In recent trading, Biogen Inc (BIIB) stock price has shown some volatility, fluctuating -5.91% over the last ...

Samsung Biologics has announced another significant manufacturing agreement, securing a $668m contract with a Europe-based ...

Mizuho lowered the firm’s price target on Biogen (BIIB) to $207 from $251 and keeps an Outperform rating on the shares. The analyst updated ...